| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 10, 342-355, Copyright © 1996 by Endocrine Society
ARTICLES |
S Dhanvantari, NG Seidah and PL Brubaker
Department of Physiology, University of Toronto, Ontario, Canada.
Proglucagon (proG) is processed in a tissue-specific manner to glucagon in the pancreas and to gilcentin, oxyntomodulin, glucagon-like peptide (GLP)-1, and GLP-2 in the intestine. Recombinant vaccinia virus (vv) vectors were used to infect prohormone convertase 1 (PC1) or PC2 into nonendocrine (BHK-proG) cells, which stably express proG. Similarly, endocrine (GH3, AtT-20) cells were coinfected with proG along with PC1 or PC2 alone, or in combination with furin, PACE4, PC5a, or PC5b. Cell extracts were analyzed for various proG-derived peptides by RIA of fractions obtained from HPLC. Upon infection of BHK-proG cells with either vv: furin or vv:PC1, glicentin was produced, while vv: PC2 did not process proG. In GH3 and AtT-20 cells, vv:PC1 produced glicentin, oxyntomodulin, GLP-1(1-37), GLP-1(7-37), and GLP-2. All other enzymes tested produced only glicentin. Interestingly, no enzyme or combination produced glucagon. Coinfection of GH3 cells with vv:PC2 and members of the chromogranin family of peptides, including chromogranin A and B and secretogranin II, as well as the PC2-binding protein 7B2, did not result in processing to glucagon. It is concluded that: 1) PC1 is responsible for the processing of proG to produce the intestinal peptides glicentin, oxyntomodulin, GLP-1(1-37), GLP-1(7-37), and GLP-2, and 2) PC2 processes proG to glicentin but does not produce glucagon, alone or in combination with other enzymes or with known molecular chaperones.
This article has been cited by other articles:
![]() |
J. E S Ardill Circulating markers for endocrine tumours of the gastroenteropancreatic tract Ann Clin Biochem, November 1, 2008; 45(6): 539 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maida, J. A. Lovshin, L. L. Baggio, and D. J. Drucker The Glucagon-Like Peptide-1 Receptor Agonist Oxyntomodulin Enhances {beta}-Cell Function but Does Not Inhibit Gastric Emptying in Mice Endocrinology, November 1, 2008; 149(11): 5670 - 5678. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Parlevliet, A. C. Heijboer, J. P. Schroder-van der Elst, L. M. Havekes, J. A. Romijn, H. Pijl, and E. P. M. Corssmit Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E142 - E147. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Wideman, S. D. Covey, G. C. Webb, D. J. Drucker, and T. J. Kieffer A Switch From Prohormone Convertase (PC)-2 to PC1/3 Expression in Transplanted {alpha}-Cells Is Accompanied by Differential Processing of Proglucagon and Improved Glucose Homeostasis in Mice Diabetes, November 1, 2007; 56(11): 2744 - 2752. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. McDonagh, J. Lee, A. Izzo, and P. L. Brubaker Role of glial cell-line derived neurotropic factor family receptor {alpha}2 in the actions of the glucagon-like peptides on the murine intestine Am J Physiol Gastrointest Liver Physiol, August 1, 2007; 293(2): G461 - G468. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Anini, A. Izzo, G. Y. Oudit, P. H. Backx, and P. L. Brubaker Role of phosphatidylinositol-3 kinase-{gamma} in the actions of glucagon-like peptide-2 on the murine small intestine Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1599 - E1606. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Lim and P. L. Brubaker Glucagon-Like Peptide 1 Secretion by the L-Cell: The View From Within Diabetes, December 1, 2006; 55(Supplement_2): S70 - S77. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Wideman, I. L. Y. Yu, T. D. Webber, C. B. Verchere, J. D. Johnson, A. T. Cheung, and T. J. Kieffer Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1) PNAS, September 5, 2006; 103(36): 13468 - 13473. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Lloyd, S. Bohan, and N. Gekakis Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice Hum. Mol. Genet., June 1, 2006; 15(11): 1884 - 1893. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ferrone and J. S Scolapio Teduglutide for the Treatment of Short Bowel Syndrome Ann. Pharmacother., June 1, 2006; 40(6): 1105 - 1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thyssen, E. Arany, and D. J. Hill Ontogeny of Regeneration of {beta}-Cells in the Neonatal Rat after Treatment with Streptozotocin Endocrinology, May 1, 2006; 147(5): 2346 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-J. Kim, O. D. Carlson, H.-J. Jang, D. Elahi, C. Berry, and J. M. Egan Peptide YY Is Secreted after Oral Glucose Administration in a Gender-Specific Manner J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6665 - 6671. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M Sinclair and D. J. Drucker Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential Physiology, October 1, 2005; 20(5): 357 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Lovshin, Q. Huang, R. Seaberg, P. L. Brubaker, and D. J. Drucker Extrahypothalamic Expression of the Glucagon-Like Peptide-2 Receptor Is Coupled to Reduction of Glutamate-Induced Cell Death in Cultured Hippocampal Cells Endocrinology, July 1, 2004; 145(7): 3495 - 3506. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ugleholdt, X. Zhu, C. F. Deacon, C. Orskov, D. F. Steiner, and J. J. Holst Impaired Intestinal Proglucagon Processing in Mice Lacking Prohormone Convertase 1 Endocrinology, March 1, 2004; 145(3): 1349 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Bandali, M. P. Belanger, and C. Wittnich Does hyperoxia affect glucose regulation and transport in the newborn? J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1730 - 1735. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Estall and D. J. Drucker Dual Regulation of Cell Proliferation and Survival via Activation of Glucagon-Like Peptide-2 Receptor Signaling J. Nutr., November 1, 2003; 133(11): 3708 - 3711. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Walsh, B. Yusta, M. P. DaCambra, Y. Anini, D. J. Drucker, and P. L. Brubaker Glucagon-Like Peptide-2 Receptor Activation in the Rat Intestinal Mucosa Endocrinology, October 1, 2003; 144(10): 4385 - 4392. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Anini and P. L. Brubaker Role of Leptin in the Regulation of Glucagon-Like Peptide-1 Secretion Diabetes, February 1, 2003; 52(2): 252 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Flock and D. J. Drucker Pax-2 Activates the Proglucagon Gene Promoter But Is Not Essential for Proglucagon Gene Expression or Development of Proglucagon-Producing Cell Lineages in the Murine Pancreas or Intestine Mol. Endocrinol., October 1, 2002; 16(10): 2349 - 2359. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Brubaker, D. J. Drucker, S. L. Asa, C. Swallow, M. Redston, and G. R. Greenberg Prolonged Gastrointestinal Transit in a Patient with a Glucagon-Like Peptide (GLP)-1- and -2-Producing Neuroendocrine Tumor J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3078 - 3083. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Dakin, I. Gunn, C. J. Small, C. M. B. Edwards, D. L. Hay, D. M. Smith, M. A. Ghatei, and S. R. Bloom Oxyntomodulin Inhibits Food Intake in the Rat Endocrinology, October 1, 2001; 142(10): 4244 - 4250. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Drucker Glucagon-Like Peptide 2 J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1759 - 1764. [Abstract] [Full Text] |
||||
![]() |
A. S. Rocca, J. LaGreca, J. Kalitsky, and P. L. Brubaker Monounsaturated Fatty Acid Diets Improve Glycemic Tolerance through Increased Secretion of Glucagon-Like Peptide-1 Endocrinology, March 1, 2001; 142(3): 1148 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Drucker Minireview: The Glucagon-Like Peptides Endocrinology, February 1, 2001; 142(2): 521 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dhanvantari, A. Izzo, E. Jansen, and P. L. Brubaker Coregulation of Glucagon-Like Peptide-1 Synthesis with Proglucagon and Prohormone Convertase 1 Gene Expression in Enteroendocrine GLUTag Cells Endocrinology, January 1, 2001; 142(1): 37 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lovshin, B. Yusta, I. Iliopoulos, A. Migirdicyan, L. Dableh, P. L. Brubaker, and D. J. Drucker Ontogeny of the Glucagon-Like Peptide-2 Receptor Axis in the Developing Rat Intestine Endocrinology, November 1, 2000; 141(11): 4194 - 4201. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Apletalina, L. Muller, and I. Lindberg Mutations in the Catalytic Domain of Prohormone Convertase 2 Result in Decreased Binding to 7B2 and Loss of Inhibition with 7B2 C-terminal Peptide J. Biol. Chem., May 5, 2000; 275(19): 14667 - 14677. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kieffer and J. Francis Habener The Glucagon-Like Peptides Endocr. Rev., December 1, 1999; 20(6): 876 - 913. [Abstract] [Full Text] |
||||
![]() |
A. B. Damholt, A. M. J. Buchan, J. J. Holst, and H. Kofod Proglucagon Processing Profile in Canine L Cells Expressing Endogenous Prohormone Convertase 1/3 and Prohormone Convertase 2 Endocrinology, October 1, 1999; 140(10): 4800 - 4808. [Abstract] [Full Text] |
||||
![]() |
A. S. Rocca and P. L. Brubaker Role of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion Endocrinology, April 1, 1999; 140(4): 1687 - 1694. [Abstract] [Full Text] |
||||
![]() |
A. Viale, C. Ortola, G. Hervieu, M. Furuta, P. Barbero, D. F. Steiner, N. G. Seidah, and J.-L. Nahon Cellular Localization and Role of Prohormone Convertases in the Processing of Pro-melanin Concentrating Hormone in Mammals J. Biol. Chem., March 5, 1999; 274(10): 6536 - 6545. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Brubaker, J. Schloos, and D. J. Drucker Regulation of Glucagon-Like Peptide-1 Synthesis and Secretion in the GLUTag Enteroendocrine Cell Line Endocrinology, October 1, 1998; 139(10): 4108 - 4114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dhanvantari and P. L. Brubaker Proglucagon Processing in an Islet Cell Line: Effects of PC1 Overexpression and PC2 Depletion Endocrinology, April 1, 1998; 139(4): 1630 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Rouille, S. Kantengwa, J.-C. Irminger, and P. A. Halban Role of the Prohormone Convertase PC3 in the Processing of Proglucagon to Glucagon-like Peptide 1 J. Biol. Chem., December 26, 1997; 272(52): 32810 - 32816. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Drucker, L. Deforest, and P. L. Brubaker Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2 Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1252 - G1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Brubaker, A. Crivici, A. Izzo, P. Ehrlich, C.-H. Tsai, and D. J. Drucker Circulating and Tissue Forms of the Intestinal Growth Factor, Glucagon-Like Peptide-2 Endocrinology, November 1, 1997; 138(11): 4837 - 4843. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Fischer, S. Dhanvantari, D. J. Drucker, and P. L. Brubaker Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E815 - E820. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Irwin, M. Satkunarajah, Y. Wen, P. L. Brubaker, R. A. Pederson, and M. B. Wheeler The Xenopus proglucagon gene encodes novel GLP-1-like peptides with insulinotropic properties PNAS, July 22, 1997; 94(15): 7915 - 7920. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Furuta, H. Yano, A. Zhou, Y. Rouille, J. J. Holst, R. Carroll, M. Ravazzola, L. Orci, H. Furuta, and D. F. Steiner Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2 PNAS, June 24, 1997; 94(13): 6646 - 6651. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. E. Chen and D. J. Drucker Tissue-specific Expression of Unique mRNAs That Encode Proglucagon-derived Peptides or Exendin 4in the Lizard J. Biol. Chem., February 14, 1997; 272(7): 4108 - 4115. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Baggio, F. Adatia, T. Bock, P. L. Brubaker, and D. J. Drucker Sustained Expression of Exendin-4 Does Not Perturb Glucose Homeostasis, beta -Cell Mass, or Food Intake in Metallothionein-Preproexendin Transgenic Mice J. Biol. Chem., October 27, 2000; 275(44): 34471 - 34477. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Furuta, A. Zhou, G. Webb, R. Carroll, M. Ravazzola, L. Orci, and D. F. Steiner Severe Defect in Proglucagon Processing in Islet A-cells of Prohormone Convertase 2 Null Mice J. Biol. Chem., July 13, 2001; 276(29): 27197 - 27202. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |